Harmony Biosciences Acquires US Rights to Pitolisant from Bioprojet; Raises $270 Million in Equity Financing
5 October 2017
Download
ObsEva Completes Patient Recruitment for Phase 3 IVF Trial
6 September 2017
Download
Trends und Chancen für den Anleger
1 September 2017
Download
Strong Vital Signs in Biotech Innovation
1 September 2017
Download
Fokus auf Innovation
1 September 2017
Download
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
29 August 2017
Download
Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension
15 August 2017
Download
Homology Medicines Raises $83.5 Million Series B Round to Advance Gene Therapy Gene Editing
1 August 2017
Download
Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA
27 July 2017
Download
HBM & Existing Investors Double Down on 1mg with a $15M Series C Financing
26 July 2017
Download
Complexa Raises $62 Million in Series C Financing to Test CXA-10 in Two Orphan Disease Proof-of-Concept Trials
26 July 2017
Download
Shape Memory Medical Raises Series B, Led by HBM Healthcare Investments Ltd.
25 July 2017
Download
Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors
21 July 2017
Download
Amphora Medical Closes $35.5 Million Series B Financing
20 July 2017
Download
Paratek Announces Phase 3 Study of Oral-Only Dosing of Omadacycline Met All Primary and Secondary FDA and Endpoints in Acute Bacterial Skin Infections
17 July 2017
Download
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
31 May 2017
Download
Wie Anleger erfolgreich in Biotech investieren
27 May 2017
Download
Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID 100 and Closing of Series B Financing
15 May 2017
Download
Amicus SA Receives Support and Growth Capital from HBM Healthcare Investments
27 April 2017
Download
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
3 April 2017
Download
Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne
27 March 2017
Download
ObsEva Starts Phase 3 Clinical Program for Nolasiban in ART
7 March 2017
Download
Trump und Big Pharma sind eine Hassliebe
4 February 2017
Download
Vascular Dynamics? Announces Expedited Access Pathway Designation by FDA for MobiusHD® to Accelerate US Access for Treatment of Resistant Hypertension
1 February 2017
Download
Fondsspezialitäten und ihre Macher
1 February 2017
Download